Royal Bank of Canada’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.46M Buy
390,155
+375,719
+2,603% +$5.26M ﹤0.01% 2275
2025
Q1
$196K Sell
14,436
-3,075
-18% -$41.8K ﹤0.01% 4370
2024
Q4
$357K Sell
17,511
-4,420
-20% -$90.1K ﹤0.01% 3905
2024
Q3
$639K Buy
21,931
+6,652
+44% +$194K ﹤0.01% 3492
2024
Q2
$354K Buy
15,279
+8,220
+116% +$190K ﹤0.01% 3919
2024
Q1
$146K Sell
7,059
-31,782
-82% -$657K ﹤0.01% 4509
2023
Q4
$834K Buy
38,841
+20,867
+116% +$448K ﹤0.01% 3317
2023
Q3
$371K Buy
17,974
+7,458
+71% +$154K ﹤0.01% 3816
2023
Q2
$310K Buy
10,516
+1,429
+16% +$42.1K ﹤0.01% 3953
2023
Q1
$209K Sell
9,087
-10,134
-53% -$233K ﹤0.01% 4222
2022
Q4
$535K Buy
19,221
+15,206
+379% +$423K ﹤0.01% 3619
2022
Q3
$123K Sell
4,015
-9,392
-70% -$288K ﹤0.01% 4696
2022
Q2
$394K Buy
13,407
+5,026
+60% +$148K ﹤0.01% 3847
2022
Q1
$269K Sell
8,381
-862
-9% -$27.7K ﹤0.01% 4357
2021
Q4
$412K Buy
9,243
+5,175
+127% +$231K ﹤0.01% 4148
2021
Q3
$205K Sell
4,068
-7,296
-64% -$368K ﹤0.01% 4644
2021
Q2
$892K Sell
11,364
-24,617
-68% -$1.93M ﹤0.01% 3354
2021
Q1
$2.06M Buy
35,981
+12,040
+50% +$688K ﹤0.01% 2607
2020
Q4
$2.01M Buy
23,941
+22,341
+1,396% +$1.87M ﹤0.01% 2509
2020
Q3
$57K Buy
1,600
+310
+24% +$11K ﹤0.01% 4805
2020
Q2
$31K Sell
1,290
-153
-11% -$3.68K ﹤0.01% 4943
2020
Q1
$25K Sell
1,443
-3,905
-73% -$67.7K ﹤0.01% 4947
2019
Q4
$93K Buy
5,348
+4,948
+1,237% +$86K ﹤0.01% 4538
2019
Q3
$6K Hold
400
﹤0.01% 5309
2019
Q2
$8K Sell
400
-7
-2% -$140 ﹤0.01% 5235
2019
Q1
$9K Sell
407
-379
-48% -$8.38K ﹤0.01% 5142
2018
Q4
$16K Sell
786
-742
-49% -$15.1K ﹤0.01% 4928
2018
Q3
$34K Buy
1,528
+1,485
+3,453% +$33K ﹤0.01% 4814
2018
Q2
$1K Sell
43
-25
-37% -$581 ﹤0.01% 5757
2018
Q1
$1K Sell
68
-932
-93% -$13.7K ﹤0.01% 5576
2017
Q4
$16K Buy
+1,000
New +$16K ﹤0.01% 4939